S
Sharon Sharir
Researcher at University of Toronto
Publications - 8
Citations - 288
Sharon Sharir is an academic researcher from University of Toronto. The author has contributed to research in topics: Bladder cancer & Semen. The author has an hindex of 6, co-authored 8 publications receiving 273 citations. Previous affiliations of Sharon Sharir include Humber River Regional Hospital & Sunnybrook Health Sciences Centre.
Papers
More filters
Journal ArticleDOI
Prevalence of abnormal sperm DNA denaturation in fertile and infertile men
TL;DR: The data show that sperm DD negatively correlates with standard semen parameters and that an isolated abnormality of sperm DD, a marker of sperm DNA integrity, is uncommon in infertile men.
Journal ArticleDOI
Progression detection of stage i nonseminomatous testis cancer on surveillance: implications for the followup protocol
Sharon Sharir,Michael A.S. Jewett,Jeremy Sturgeon,Malcolm J. Moore,Padraig Warde,Charles Catton,Mary Gospodarowicz +6 more
TL;DR: In stage I nonseminoma patients, surveillance history, physical examination, tumor markers and abdominopelvic CT are necessary components of the followup protocol and should be followed beyond 5 years and likely for life in addition to regular patient self-examination.
Journal ArticleDOI
Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer.
Frances C. Wright,D. Crooks,D. Crooks,Margaret I. Fitch,Margaret I. Fitch,E. Hollenberg,B.A. Maier,E. Greco,D. Miller,Calvin Law,Sharon Sharir,Neil Fleshner,Andrew J. Smith,Andrew J. Smith +13 more
TL;DR: Patients with locally advanced rectal cancer (LARC) and locally recurrent rectum cancer (LRRC) represent a complex management challenge and there is potential for cure in a subset of patients, the cost in terms of morbidity can be high.
Journal ArticleDOI
Lymph node assessment and lymphadenectomy in bladder cancer.
TL;DR: There is no consensus regarding the optimal extent of lymphadenectomy and number of nodes that should be assessed and there is evidence that the quality of regional node dissection is associated with oncologic outcome.
Journal ArticleDOI
Urologic complications of composite resection following combined modality treatment of colorectal cancer.
Peter K. Stotland,Peter K. Stotland,Kouros Moozar,Kouros Moozar,Jonathan A. Cardella,Jonathan A. Cardella,Neil Fleshner,Sharon Sharir,Sharon Sharir,Andrew J. Smith,Andrew J. Smith,Carol J. Swallow,Carol J. Swallow +12 more
TL;DR: Only 24% of patients who underwent ureteric reconstruction following composite resection developed a urologic complication that required intervention, suggesting optimization of surgical technique at the time of en bloc resection may obviate the need for subsequent revision.